At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,090 enrolled
Drug / intervention
Azilsartan/Amlodipinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Azilsartan/Amlodipine (Zacras) Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"
In Brief
An observational study evaluating Azilsartan/Amlodipine for Hypertension. Completed, enrolled 1,090 participants across 2 sites.
Detailed Summary
The purpose of this survey is to evaluate the safety and efficacy of long-term use of azilsartan/amlodipine combination tablets Low Dose (LD) \& High Dose (HD) (Zacras Combination Tablets LD \& HD) in hypertensive patients in daily medical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
First PostedJul 2014
Primary CompletionJan 2017
TodayJul 2026
First PostedJul 4, 2014
Enrollment StartJun 26, 2014
Primary CompletionJan 31, 2017
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 12.0 years ago
Interventions
Azilsartan/Amlodipinedrug
Azilsartan/Amlodipine combination tablets LD \& HD